homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

May 12, 2003

Helix BioMedix

Daniel O. Wilds and John C. Fiddes have joined the board of directors of Bothell's Helix BioMedix. Wilds is the president, chief executive officer and chairman of the board of directors of Northwest Biotherapeutics. Fiddes is a consultant to the biotechnology industry, with over 20 years experience in drug discovery and development, recently serving as chief executive officer of Tao Biosciences. Helix BioMedix is an early-stage biotechnology company developing and commercializing bioactive peptides.




Email or user name:
Password:
 
Forgot password? Click here.